Perturbed tumor vasculature and activation of AMPK and interferons are well-established anti-tumorigenic pathways [33–35] that likely underline, at least in part, the attenuation of tumor growth by Hpa2-Nuc. The gene discussed is NUCB1; the disease is neoplasm.